Colon Cancer

Showing NaN - NaN of 19

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Collection of Blood From Patients With Cancer

Recruiting
  • Prostate Cancer
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Where Culture Meets Genetics: Exploring Latinas Causal

    Completed
    • Colon Cancer
    • Breast Cancer
      • Bethesda, Maryland
        National Human Genome Research Institute (NHGRI)
      Jan 21, 2023

      Colon Cancer, Colorectal Cancer, Rectal Cancer Trial in Worldwide (Panitumumab, Bevacizumab, mFOLFOX6)

      Completed
      • Colon Cancer
      • +3 more
      • Birmingham, Alabama
      • +94 more
      Nov 10, 2022

      Subjects Previously Enrolled in Poxviral Vector Gene Transfer

      Recruiting
      • Prostate Cancer
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Aug 19, 2022

        Genomic Services Research Program

        Recruiting
        • Colon Cancer
        • Breast Cancer
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Aug 12, 2022

          Mobile Sensor Technologies to Assess General Symptomology of

          Enrolling by invitation
          • Neoplasms
          • +4 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Jul 20, 2022

            Colon Cancer, Pancreatic Cancer, Cholangiocarcinoma Trial run by the National Cancer Institute (NCI) (MVT-5873, pancreatectomy

            Completed
            • Colon Cancer
            • +4 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Jun 30, 2022

            Colon Cancer Trial in United States (Bevacizumab, Cetuximab, 5-fluorouracil)

            Completed
            • Colon Cancer
            • Evansville, Indiana
            • +9 more
            Dec 14, 2021

            Tumors, Prostate Cancer, Lung Cancer Trial run by the NCI (ETBX-051; adenoviral brachyury vaccine, ETBX-061; adenoviral Mucin-1

            Completed
            • Neoplasms
            • +4 more
            • ETBX-051; adenoviral brachyury vaccine
            • +2 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Aug 25, 2020

            Melanoma, Colon Cancer, Gastrointestinal Cancer Trial run by the NCI (National Cancer Institute (NCI)-4650, a messenger

            Terminated
            • Melanoma
            • +4 more
            • National Cancer Institute (NCI)-4650, a messenger ribonucleic acid (mRNA)-based, Personalized Cancer Vaccine
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            May 22, 2020

            Colonic Tumors, Cancer of the Colon, Colon Cancer Trial run by the NCI (Cetuximab, AZD6244)

            Completed
            • Colonic Neoplasms
            • +4 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            Dec 14, 2019

            Testing a Spanish Version of a Patient Toxicity Questionnaire

            Completed
            • Breast Cancer
            • +4 more
              • Bethesda, Maryland
                National Cancer Institute (NCI), 9000 Rockville Pike
              Dec 13, 2019

              Breast Cancer, Prostate Cancer, Lung Cancer Trial run by the NCI (111Indium CHX-A)

              Terminated
              • Breast Cancer
              • +3 more
              • 111Indium CHX-A
              • Bethesda, Maryland
                National Institutes of Health Clinical Center, 9000 Rockville Pi
              Mar 8, 2019

              Renal Cell Carcinoma, Breast Cancer, Colon Cancer Trial in Bethesda, Hershey, Pittsburgh (DMS 612)

              Completed
              • Renal Cell Carcinoma
              • +4 more
              • DMS 612
              • Bethesda, Maryland
              • +2 more
              Dec 4, 2018

              Cancer, Colon Cancer, Colorectal Cancer Trial in Worldwide (Pegfilgrastim, Placebo, Bevacizumab)

              Completed
              • Cancer
              • +7 more
              • Muscle Shoals, Alabama
              • +153 more
              Dec 5, 2017

              Breast Cancer, Colon Cancer, Pancreatic Cancer Trial run by the NCI (p53: 264-272 peptide, CT-011)

              Withdrawn
              • Breast Cancer
              • +4 more
              • Bethesda, Maryland
                National Institutes of Health Clinical Center, 9000 Rockville Pi
              Jun 30, 2017

              Colon Cancer, Lung Cancer, Cervical Cancer Trial run by the NCI ((18)Fluciclatide)

              Withdrawn
              • Colon Cancer
              • +4 more
              • Bethesda, Maryland
                National Institutes of Health Clinical Center, 9000 Rockville Pi
              Jun 30, 2017

              Breast Cancer, Colon Cancer, Bladder Cancer Trial in Bethesda, New York (Glycosylated Recombinant Human Interleukin-7,

              Terminated
              • Breast Cancer
              • +2 more
              • Glycosylated Recombinant Human Interleukin-7
              • +5 more
              • Bethesda, Maryland
              • +1 more
              May 16, 2016